Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
NovelStem International Corp. is a holding company focused on biotech investments, primarily owning interests in NewStem Ltd., an Israeli biotech developing stem cell-based diagnostics and therapeutics, and a joint venture in entertainment properties. The company’s core activities involve managing biotech assets, licensing technology, and pursuing innovative medical research. It relies on investments and strategic partnerships, with a focus on advancing regenerative medicine and cancer diagnostics.
This description was generated via AI from an annual report. Updated about 1 year ago.